Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatric Transplants

Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients

Abstract

Idiopathic pneumonia syndrome (IPS) is a rare complication following stem cell transplant (SCT) and its incidence among pediatric SCT recipients is not known. To assess the incidence of IPS, we retrospectively reviewed the incidence of IPS at our center. IPS is defined as the presence of multilobar infiltrates by chest radiograph or computed tomography scan, need for supplemental oxygenation with declining pulse oximetry and no identifiable pulmonary infection. Between July 1999 and August 2005, 11 of 93 children who received a fully ablative allogeneic SCT (11.8%) developed IPS. All 11 patients had normal pulmonary evaluation before transplant. IPS developed at a median of 17 days (range 8–42 days) after transplant. Recipients of unrelated donor transplant had increased risk of developing IPS. There was a significant association between acute or hyperacute graft-versus-host disease (GVHD) and IPS (P=0.035). All patients had significant hypoxia and five patients required assisted ventilation. IPS was the cause of death in two patients. Although there was complete resolution of respiratory symptoms in the other nine patients, overall transplant-related mortality was significantly higher among patients with IPS (64 vs 17%, P=0.002). IPS is a relatively common complication in pediatric SCT recipients and acute GVHD is an important associated factor.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Geller RB, Vogelsang GB, Wingard JR, Yeager AM, Burns WH, Santos GW et al. Successful marrow transplantation for acute myelocytic leukemia following therapy for Hodgkin's disease. J Clin Oncol 1988; 6: 1558–1561.

    Article  CAS  PubMed  Google Scholar 

  2. Weiner RS, Dicke KA . Risk factors for interstitial pneumonitis following allogeneic bone marrow transplantation for severe aplastic anemia: a preliminary report. Transplant Proc 1987; 19 (Part 3): 2639–2642.

    CAS  PubMed  Google Scholar 

  3. Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW . Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63: 1079–1086.

    Article  CAS  PubMed  Google Scholar 

  4. Crawford SW, Hackman RC . Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993; 147 (Part 1): 1393–1400.

    Article  CAS  PubMed  Google Scholar 

  5. Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.

    Article  CAS  PubMed  Google Scholar 

  6. Shankar G, Cohen DA . Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis. Int J Exp Pathol 2001; 82: 101–113.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Della Volpe A, Ferreri AJ, Annaloro C, Mangili P, Rosso A, Calandrino R et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys 2002; 52: 483–488.

    Article  PubMed  Google Scholar 

  8. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH . NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147 (Part 1): 1601–1606.

    Article  CAS  PubMed  Google Scholar 

  9. Pecego R, Hill R, Appelbaum FR, Amos D, Buckner CD, Fefer A et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1986; 42: 515–517.

    Article  CAS  PubMed  Google Scholar 

  10. Granena A, Carreras E, Rozman C, Salgado C, Sierra J, Algara M et al. Interstitial pneumonitis after BMT: 15 years experience in a single institution. Bone Marrow Transplant 1993; 11: 453–458.

    CAS  PubMed  Google Scholar 

  11. Meyers JD, Flournoy N, Thomas ED . Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis 1982; 4: 1119–1132.

    Article  CAS  PubMed  Google Scholar 

  12. Wingard JR, Mellits ED, Sostrin MB, Chen DY, Burns WH, Santos GW et al. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine (Baltimore) 1988; 67: 175–186.

    Article  CAS  Google Scholar 

  13. Fukuda T, Hackman RC, Guthrie KA, Sandmaier BM, Boeckh M, Maris MB et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003; 102: 2777–2785.

    Article  PubMed  Google Scholar 

  14. Yanik G, Hellerstedt B, Custer J, Hutchinson R, Kwon D, Ferrara JL et al. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 395–400.

    Article  CAS  PubMed  Google Scholar 

  15. Clark JG, Madtes DK, Martin TR, Hackman RC, Farrand AL, Crawford SW . Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. Crit Care Med 1999; 27: 1800–1806.

    Article  CAS  PubMed  Google Scholar 

  16. Weiner RS, Bortin MM, Gale RP, Gluckman E, Kay HE, Kolb HJ et al. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med 1986; 104: 168–175.

    Article  CAS  PubMed  Google Scholar 

  17. Crawford SW, Longton G, Storb R . Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993; 12: 225–231.

    CAS  PubMed  Google Scholar 

  18. Atkinson K, Nivison-Smith I, Dodds A, Concannon A, Milliken S, Downs K . A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989. Bone Marrow Transplant 1998; 21: 691–695.

    Article  CAS  PubMed  Google Scholar 

  19. Griese M, Rampf U, Hofmann D, Fuhrer M, Reinhardt D, Bender-Gotze C . Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000; 30: 393–401.

    Article  CAS  PubMed  Google Scholar 

  20. Atkinson K, Turner J, Biggs JC, Dodds A, Concannon A . An acute pulmonary syndrome possibly representing acute graft-versus-host disease involving the lung interstitium. Bone Marrow Transplant 1991; 8: 231–234.

    CAS  PubMed  Google Scholar 

  21. Down JD, Mauch P, Warhol M, Neben S, Ferrara JL . The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation. Transplantation 1992; 54: 802–808.

    Article  CAS  PubMed  Google Scholar 

  22. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte Jr J, Crawford JM et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 88: 3230–3239.

    CAS  PubMed  Google Scholar 

  23. Cooke KR, Hill GR, Gerbitz A, Kobzik L, Martin TR, Crawford JM et al. Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation. Transplantation 2000; 70: 272–279.

    Article  CAS  PubMed  Google Scholar 

  24. Cooke KR, Yanik G . Acute lung injury after allogeneic stem cell transplantation: is the lung a target of acute graft-versus-host disease? Bone Marrow Transplant 2004; 34: 753–765.

    Article  CAS  PubMed  Google Scholar 

  25. Cooke KR . Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again. Pediatr Transplant 2005; 9 (Suppl 7): 25–36.

    Article  PubMed  Google Scholar 

  26. Yanik G, Cooke KR . The lung as a target organ of graft-versus-host disease. Semin Hematol 2006; 43: 42–52.

    Article  PubMed  Google Scholar 

  27. Yanik GA, Levine JE, Ferrara JLM, Uberti JP, Ho VT, Antin JH et al. Survival following etanercept therapy for the treatment of Idiopathic pneumonia syndrome post allogeneic stem cell transplantation. Blood 2004; 104: 104A–105A.

    Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the excellent care provided by the nursing and support staff.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Frangoul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keates-Baleeiro, J., Moore, P., Koyama, T. et al. Incidence and outcome of idiopathic pneumonia syndrome in pediatric stem cell transplant recipients. Bone Marrow Transplant 38, 285–289 (2006). https://doi.org/10.1038/sj.bmt.1705436

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705436

Keywords

This article is cited by

Search

Quick links